Thyroid disease and the menopausal woman

Journal of the British Menopause Society

Volumn 9, Issue 2, 2003, Pages 82-84

  Eaton, Simon E M ^a,b   Webster, Jonathan ^a,b   Allahabadia, Amit ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN; RADIOACTIVE IODINE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; THYROID ANTIBODY; THYROID HORMONE; THYROTROPIN; THYROXINE; THYROXINE BINDING GLOBULIN;

BONE DENSITY; BONE MINERAL; BONE TURNOVER; BREAST CANCER; CANCER RISK; CLINICAL PRACTICE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MEGADOSE; DRUG WITHDRAWAL; EARLY MENOPAUSE; GOITER; HASHIMOTO DISEASE; HOMEOSTASIS; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MENOPAUSAL SYNDROME; MENOPAUSE; OSTEOLYSIS; OSTEOPOROSIS; OVARY INSUFFICIENCY; POSTMENOPAUSE; PREVALENCE; REVIEW; SCREENING TEST; THYROID CANCER; THYROID DISEASE; THYROID FUNCTION; THYROID FUNCTION TEST; THYROID HORMONE BLOOD LEVEL; THYROTOXICOSIS;

FEMALE; HUMANS; MENOPAUSE; THYROID DISEASES; WOMEN'S HEALTH;

EID: 0037829950     PISSN: 13621807     EISSN: None     Source Type: Journal    
DOI: 10.1258/136218003100322134     Document Type: Review

References (19)

1. Sawin T. Intrinsic and extrinsic variables. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's The Thyroid, pp 254-280, Philadelphia: Lippincot Williams and Wilkins, 2000.
2. Utiger RD. Estrogen, thyroxine binding in serum, and thyroxine therapy. N Engl J Med 2001; 344: 1784-1785
3. Massoudi MS, Meilahn EN, Orchard TJ, et al. Prevalence of thyroid antibodies among healthy middle-aged women. Findings from the thyroid study in healthy women. Ann Epidemiol 1995; 5: 229-233.
4. Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med 2001; 344: 1743-1749.
5. Gordon D, Beastall GH, McArdle CS, Thomson JA. The effect of tamoxifen therapy on thyroid function tests. Cancer 1986; 58: 1422-1425.
6. Mamby CC, Love RR, Lee KE. Thyroid function test changes with adjuvant tamoxifen therapy in postmenopausal women with breast cancer. J Clin Oncol 1995; 13: 854-857.
7. Anker GB, Lonning PE, Aakvaag A, Lien EA. Thyroid function in postmenopausal breast cancer patients treated with tamoxifen. Scand J Clin Lab Invest 1998; 8: 103-107.
8. Zidan J, Rubenstein W. Effect of adjuvant tamoxifen therapy on thyroid function in postmenopausal women with breast cancer. Oncology 1999; 56: 43-45.
9. Franceschi S, Fassina A, Talamini R, et al. The influence of reproductive and hormonal factors on thyroid cancer in women. Rev Epidemiol Sante Publique 1990; 38: 27-34.
10. Mack WJ, Preston-Martin S, Bernstein L, et al. Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females. Cancer Epidemiol Biomarkers Prev 1999; 8: 991-997.
11. Akslen LA, Nilssen S, Kvale G. Reproductive factors and the risk of thyroid cancer. A prospective study of 63090 women from Norway. Br J Cancer 1992; 65: 772-774.
12. Negri E, Dal Maso L, Ron E, et al. A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 1999; 10: 143-155.
13. 131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: Results of a retrospective study. J Clin Endocrinol Metab 2001; 86: 3512-3515.
14. Greenspan SL, Greenspan FS. The effect of thyroid hormone on skeletal integrity. Ann Intern Med 1999; 130: 750-758.
15. Hallengren B, Elmstahl B, Berglund J, et al. No increase in fracture incidence in patients treated for thyrotoxicosis in Malmo during 1970-74. A 20-year population-based follow-up. J Intern Med 1999; 246: 139-44.
16. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995; 332: 767-773.
17. Schneider DL, Barrett-Connor EL, Morton DJ. Thyroid hormone use and bone mineral density in elderly women. Effects of estrogen. JAMA 1994; 271: 1245-1249.
18. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43: 55-68.
19. Weetman AP. Fortnightly review: Hypothyroidism: Screening and subclinical disease. BMJ 1997; 314: 1175.